Skip to main content
SpringerLink
Log in

The revised German Cystic Fibrosis Questionnaire: Validation of a disease-specific health-related quality of life instrument

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Background: The assessment of health related quality of life (HRQOL) has increasingly been recognized as an important adjunct to medical outcome parameters in the monitoring of cystic fibrosis (CF) patients and in clinical studies. The Cystic Fibrosis Questionnaire (CFQ) is a disease-specific HRQOL instrument for CF patients developed in France. Translations are currently being validated in four different countries. The aim of the present study was to validate the German adaptation of the CFQ-14+. Method: On the basis of results from a first dataset (n = 197 CF adolescent and adult patients), revisions were made and retested in a second sample of 103 patients. Results: The final revised version showed good construct validity. The same nine HRQOL domains as in the French original CFQ-14+ emerged from the analyses as structurally robust scales. The internal consistencies of the HRQOL scales ranged from 0.71 to 0.94. The instrument's clinical validity was supported by severely ill patients reporting lower HRQOL than less severely ill patients on most scales. Conclusion: We conclude that the evidence supports the validity and reliability of the instrument. An important future area of application is the use in comparative multi-center international studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Quittner AL. Measurement of quality of life in cystic fibrosis. Curr Opin Pulm Med 1998; 4: 326–331.

    Google Scholar 

  2. Bradley J, McAlister O, Elborn S. Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis. Eur Respir J 2001; 17: 712–715.

    Google Scholar 

  3. Staab D, Wenninger K, Gebert N, et al. Quality of life in patients with cystic fibrosis and their parents: What is important besides disease severity? Thorax 1998; 53: 727–731.

    Google Scholar 

  4. Kaplan RM, Bush JW, Berry CC. The reliability, stability and generalizability of a health status index. American Statistical Association; Proceedings from Social Statistics Section. American Statistical Association, 1978: 704–709.

  5. Munzenberger PJ, Van Wagnen CA, Abdulhamid I, Walker PC. Quality of life as a treatment outcome in patients with cystic fibrosis. Pharmacotherapy 1999; 19: 393–398.

    Google Scholar 

  6. Orenstein DM, Nixon PA, Ross E, Kaplan R. The quality of well-being in cystic fibrosis. Chest 1989; 95: 344–347.

    Google Scholar 

  7. Orenstein DM, Pattishall EN, Nixon PA, Ross E, Kaplan R. Quality of well-being before and after antibiotic treatment of pulmonary exacerbation in patients with cystic fibrosis. Chest 1990; 98: 1081–1084.

    Google Scholar 

  8. Czyzewski DI, Mariotto MJ, Bartholomew LK, LeCompte S, Sockrider M. Measurement of quality of well-being in a child and adolescent cystic fibrosis sample. Med Care 1994; 32: 965–972.

    Google Scholar 

  9. Hunt S, Mc Ewen J, McKenna S. Measuring Health Status. London: Croom Helm, 1996.

    Google Scholar 

  10. Busschbach JJV, Horikx PE, van den Bosch JMM, Brutel de la Riviére A, de Charro FT. Measuring the quality of life before and after bilateral lung transplantation in patients with cystic fibrosis. Chest 1994; 105: 911–917.

    Google Scholar 

  11. Caine N, Sharples LD, Smyth R, et al. Survival and quality of life of cystic fibrosis patients before and after heart-lung transplantation. Transplant Proc 1991; 23: 1203–1204.

    Google Scholar 

  12. Dennis C, Caine N, Sharples L, et al. Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant 1993; 12: 893–902.

    Google Scholar 

  13. Congleton J, Hodson ME, Duncan-Skingle F. Do Nottingham Health Profile scores change over time in cystic fibrosis? Respir Med 1998; 92: 268–272.

    Google Scholar 

  14. Congleton J, Hodson ME, Duncan-Skingle F. Quality of life in adults with cystic fibrosis. Thorax 1996; 51: 936–940.

    Google Scholar 

  15. Johnson JA, Connolly M, Brown N, Zuberbuhler P, Tabak J. Health related quality of life in cystic fibrosis [abstract]. Pediatr Pulmonol 1999; 19(Suppl): 356.

    Google Scholar 

  16. Gee L, Abbott J, Conway SP, Etherington C, Webb AK. Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax 2000; 55: 946–954.

    Google Scholar 

  17. Henry-Launois B, Aussage P, Grosskopf C, Goehrs JM. Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients. Qual Life Res (in press).

  18. Henry-Launois B. Aspects psycho-sociaux et qualité de vie (Psychosocial aspects and quality of life). Référence Mucoviscidose 1997; 2: 61–63.

    Google Scholar 

  19. Henry B. Mésurer la qualité de vie sous traitement chez l'enfant: le Cystic Fibrosis Questionnaire (Assessing quality of life during child treatment: the Cystic Fibrosis Questionnaire). Référence Mucoviscidose 1998; 3: 67–70.

    Google Scholar 

  20. Quittner AL, Sweeny S, Watrous P, et al. Development of a disease-specific quality of life measure for cystic fibrosis: Linguistic validation of the French CFQ. J Pediatr Psychol 2000; 25: 403–414.

    Google Scholar 

  21. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines. J Clin Epidemiol 1993; 46: 1417–1432.

    Google Scholar 

  22. Mathias SD, Fifer SK, Patrick DL. Rapid translation of quality of life measures for international clinical trials: Avoiding errors in the minimalist approach. Qual Life Res 1994; 3: 403–412.

    Google Scholar 

  23. Wenninger K, Staab D, Henry B, Wahn U & the German CF study group. Der Fragebogen zur Lebensqualität bei Cystischer Fibrose-Reliabilität und Validität der deutschen Adaptation (The questionnaire on quality of life in cystic fibrosis patients-reliability and validity of the German adaptation). Zeitschrift für Medizinische Psychologie 1999; 3: 121–128.

    Google Scholar 

  24. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: Statistics and strategies for evaluation. Control Clin Trials 1991; 12: 142S–158S.

    Google Scholar 

  25. Bortz J. Statistik für Sozialwissenschaftler (Statistics for the social sciences). 4th ed., Berlin, Heidelberg: Springer, 1993.

    Google Scholar 

  26. Wiedemann B. Qualitätssicherung Mukoviszidose-Ñberblick über den Gesundheitszustand der Patienten in Deutschland 2000. (Qualitymanagemen t in cystic fibrosis-Overview of the health status of German patients, 2000). Zentrum für Qualitätsmanagement im Gesundheitswesen, Ärztekammer Hannover, August, 2001.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department for Paediatric Pneumology and Immunology, Charité-Humboldt University, Germany

    Kerstin Wenninger, Ulrich Wahn & Doris Staab

  2. MDS Pharma Services Health Economics, SA, France

    Pierre Aussage

Authors
  1. Kerstin Wenninger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pierre Aussage
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ulrich Wahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Doris Staab
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wenninger, K., Aussage, P., Wahn, U. et al. The revised German Cystic Fibrosis Questionnaire: Validation of a disease-specific health-related quality of life instrument. Qual Life Res 12, 77–85 (2003). https://doi.org/10.1023/A:1022011704399

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022011704399

Search

Navigation